ACM Global Laboratories HOLDINGS
ACM Global Laboratories provides bioanalysis and central laboratory services for clinical trials, including large‑molecule and PK bioanalysis, biomarker analysis, and toxicology testing such as nicotine and cannabinoid research. It offers biomarker testing, flow cytometry, radiopharmaceutical services, sample collection kits and tracking, pathology and COVID‑19 research, and workplace drug monitoring. Through a network of wholly‑owned and partner facilities, it supports data‑driven decision‑making across drug development.